-
1
-
-
84989936333
-
ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs
-
Borromeo, M.D., Savage, T.K., Kollipara, R.K., He, M., Augustyn, A., Osborne, J.K., Girard, L., Minna, J.D., Gazdar, A.F., Cobb, M.H., Johnson, J.E., ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Rep. 16 (2016), 1259–1272.
-
(2016)
Cell Rep.
, vol.16
, pp. 1259-1272
-
-
Borromeo, M.D.1
Savage, T.K.2
Kollipara, R.K.3
He, M.4
Augustyn, A.5
Osborne, J.K.6
Girard, L.7
Minna, J.D.8
Gazdar, A.F.9
Cobb, M.H.10
Johnson, J.E.11
-
2
-
-
0025907433
-
myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens
-
Brennan, J., O'Connor, T., Makuch, R.W., Simmons, A.M., Russell, E., Linnoila, R.I., Phelps, R.M., Gazdar, A.F., Ihde, D.C., Johnson, B.E., myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res. 51 (1991), 1708–1712.
-
(1991)
Cancer Res.
, vol.51
, pp. 1708-1712
-
-
Brennan, J.1
O'Connor, T.2
Makuch, R.W.3
Simmons, A.M.4
Russell, E.5
Linnoila, R.I.6
Phelps, R.M.7
Gazdar, A.F.8
Ihde, D.C.9
Johnson, B.E.10
-
3
-
-
84880042989
-
Small molecule inhibitors of Aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma
-
Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H.E., Rycak, L., Jamin, Y., Thway, K., Robinson, S.P., Roels, F., et al. Small molecule inhibitors of Aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell 24 (2013), 75–89.
-
(2013)
Cancer Cell
, vol.24
, pp. 75-89
-
-
Brockmann, M.1
Poon, E.2
Berry, T.3
Carstensen, A.4
Deubzer, H.E.5
Rycak, L.6
Jamin, Y.7
Thway, K.8
Robinson, S.P.9
Roels, F.10
-
4
-
-
84962812153
-
Small cell lung cancer: can recent advances in biology and molecular biology be translated into improved outcomes?
-
Bunn, P.A. Jr., Minna, J., Augustyn, A., Gazdar, A., Ouadah, Y., Krasnow, M.A., Berns, A., Brambilla, E., Rekhtman, N., Massion, P.P., et al. Small cell lung cancer: can recent advances in biology and molecular biology be translated into improved outcomes?. J. Thorac. Oncol. 11 (2016), 453–474.
-
(2016)
J. Thorac. Oncol.
, vol.11
, pp. 453-474
-
-
Bunn, P.A.1
Minna, J.2
Augustyn, A.3
Gazdar, A.4
Ouadah, Y.5
Krasnow, M.A.6
Berns, A.7
Brambilla, E.8
Rekhtman, N.9
Massion, P.P.10
-
5
-
-
79751511326
-
A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer
-
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H.B., Meuwissen, R., Berns, A., A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19 (2011), 244–256.
-
(2011)
Cancer Cell
, vol.19
, pp. 244-256
-
-
Calbo, J.1
van Montfort, E.2
Proost, N.3
van Drunen, E.4
Beverloo, H.B.5
Meuwissen, R.6
Berns, A.7
-
6
-
-
0022006760
-
Establishment and identification of small cell lung cancer cell lines having classic and variant features
-
Carney, D.N., Gazdar, A.F., Bepler, G., Guccion, J.G., Marangos, P.J., Moody, T.W., Zweig, M.H., Minna, J.D., Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45 (1985), 2913–2923.
-
(1985)
Cancer Res.
, vol.45
, pp. 2913-2923
-
-
Carney, D.N.1
Gazdar, A.F.2
Bepler, G.3
Guccion, J.G.4
Marangos, P.J.5
Moody, T.W.6
Zweig, M.H.7
Minna, J.D.8
-
7
-
-
84919495606
-
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor
-
Christensen, C.L., Kwiatkowski, N., Abraham, B.J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G.S., Akbay, E.A., Altabef, A., et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26 (2014), 909–922.
-
(2014)
Cancer Cell
, vol.26
, pp. 909-922
-
-
Christensen, C.L.1
Kwiatkowski, N.2
Abraham, B.J.3
Carretero, J.4
Al-Shahrour, F.5
Zhang, T.6
Chipumuro, E.7
Herter-Sprie, G.S.8
Akbay, E.A.9
Altabef, A.10
-
8
-
-
84900437332
-
PTEN is a potent suppressor of small cell lung cancer
-
Cui, M., Augert, A., Rongione, M., Conkrite, K., Parazzoli, S., Nikitin, A.Y., Ingolia, N., MacPherson, D., PTEN is a potent suppressor of small cell lung cancer. Mol. Cancer Res. 12 (2014), 654–659.
-
(2014)
Mol. Cancer Res.
, vol.12
, pp. 654-659
-
-
Cui, M.1
Augert, A.2
Rongione, M.3
Conkrite, K.4
Parazzoli, S.5
Nikitin, A.Y.6
Ingolia, N.7
MacPherson, D.8
-
9
-
-
84978379634
-
Nfib promotes metastasis through a widespread increase in chromatin accessibility
-
Denny, S.K., Yang, D., Chuang, C.H., Brady, J.J., Lim, J.S., Gruner, B.M., Chiou, S.H., Schep, A.N., Baral, J., Hamard, C., et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166 (2016), 328–342.
-
(2016)
Cell
, vol.166
, pp. 328-342
-
-
Denny, S.K.1
Yang, D.2
Chuang, C.H.3
Brady, J.J.4
Lim, J.S.5
Gruner, B.M.6
Chiou, S.H.7
Schep, A.N.8
Baral, J.9
Hamard, C.10
-
10
-
-
79960463418
-
Nuclear factor I/B is an oncogene in small cell lung cancer
-
Dooley, A.L., Winslow, M.M., Chiang, D.Y., Banerji, S., Stransky, N., Dayton, T.L., Snyder, E.L., Senna, S., Whittaker, C.A., Bronson, R.T., et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25 (2011), 1470–1475.
-
(2011)
Genes Dev.
, vol.25
, pp. 1470-1475
-
-
Dooley, A.L.1
Winslow, M.M.2
Chiang, D.Y.3
Banerji, S.4
Stransky, N.5
Dayton, T.L.6
Snyder, E.L.7
Senna, S.8
Whittaker, C.A.9
Bronson, R.T.10
-
11
-
-
0023144010
-
Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients
-
Elliott, J.A., Osterlind, K., Hirsch, F.R., Hansen, H.H., Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients. J. Clin. Oncol. 5 (1987), 246–254.
-
(1987)
J. Clin. Oncol.
, vol.5
, pp. 246-254
-
-
Elliott, J.A.1
Osterlind, K.2
Hirsch, F.R.3
Hansen, H.H.4
-
12
-
-
0021968689
-
Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties
-
Gazdar, A.F., Carney, D.N., Nau, M.M., Minna, J.D., Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res. 45 (1985), 2924–2930.
-
(1985)
Cancer Res.
, vol.45
, pp. 2924-2930
-
-
Gazdar, A.F.1
Carney, D.N.2
Nau, M.M.3
Minna, J.D.4
-
13
-
-
84929949436
-
The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung
-
Gazdar, A.F., Savage, T.K., Johnson, J.E., Berns, A., Sage, J., Linnoila, R.I., MacPherson, D., McFadden, D.G., Farago, A., Jacks, T., et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J. Thorac. Oncol. 10 (2015), 553–564.
-
(2015)
J. Thorac. Oncol.
, vol.10
, pp. 553-564
-
-
Gazdar, A.F.1
Savage, T.K.2
Johnson, J.E.3
Berns, A.4
Sage, J.5
Linnoila, R.I.6
MacPherson, D.7
McFadden, D.G.8
Farago, A.9
Jacks, T.10
-
14
-
-
0025914765
-
Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice
-
Gazzeri, S., Brambilla, E., Jacrot, M., Chauvin, C., Benabid, A.L., Brambilla, C., Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res. 51 (1991), 2566–2571.
-
(1991)
Cancer Res.
, vol.51
, pp. 2566-2571
-
-
Gazzeri, S.1
Brambilla, E.2
Jacrot, M.3
Chauvin, C.4
Benabid, A.L.5
Brambilla, C.6
-
15
-
-
84938132350
-
Comprehensive genomic profiles of small cell lung cancer
-
George, J., Lim, J.S., Jang, S.J., Cun, Y., Ozretic, L., Kong, G., Leenders, F., Lu, X., Fernandez-Cuesta, L., Bosco, G., et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524 (2015), 47–53.
-
(2015)
Nature
, vol.524
, pp. 47-53
-
-
George, J.1
Lim, J.S.2
Jang, S.J.3
Cun, Y.4
Ozretic, L.5
Kong, G.6
Leenders, F.7
Lu, X.8
Fernandez-Cuesta, L.9
Bosco, G.10
-
16
-
-
84908689719
-
Drugging MYCN through an allosteric transition in Aurora kinase A
-
Gustafson, W.C., Meyerowitz, J.G., Nekritz, E.A., Chen, J., Benes, C., Charron, E., Simonds, E.F., Seeger, R., Matthay, K.K., Hertz, N.T., et al. Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer Cell 26 (2014), 414–427.
-
(2014)
Cancer Cell
, vol.26
, pp. 414-427
-
-
Gustafson, W.C.1
Meyerowitz, J.G.2
Nekritz, E.A.3
Chen, J.4
Benes, C.5
Charron, E.6
Simonds, E.F.7
Seeger, R.8
Matthay, K.K.9
Hertz, N.T.10
-
17
-
-
84905819148
-
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
-
Hodgkinson, C.L., Morrow, C.J., Li, Y., Metcalf, R.L., Rothwell, D.G., Trapani, F., Polanski, R., Burt, D.J., Simpson, K.L., Morris, K., et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat. Med. 20 (2014), 897–903.
-
(2014)
Nat. Med.
, vol.20
, pp. 897-903
-
-
Hodgkinson, C.L.1
Morrow, C.J.2
Li, Y.3
Metcalf, R.L.4
Rothwell, D.G.5
Trapani, F.6
Polanski, R.7
Burt, D.J.8
Simpson, K.L.9
Morris, K.10
-
18
-
-
84859399268
-
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735
-
Hook, K.E., Garza, S.J., Lira, M.E., Ching, K.A., Lee, N.V., Cao, J., Yuan, J., Ye, J., Ozeck, M., Shi, S.T., et al. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735. Mol. Cancer Ther. 11 (2012), 710–719.
-
(2012)
Mol. Cancer Ther.
, vol.11
, pp. 710-719
-
-
Hook, K.E.1
Garza, S.J.2
Lira, M.E.3
Ching, K.A.4
Lee, N.V.5
Cao, J.6
Yuan, J.7
Ye, J.8
Ozeck, M.9
Shi, S.T.10
-
19
-
-
84893809132
-
Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
-
Huijbers, I.J., Bin Ali, R., Pritchard, C., Cozijnsen, M., Kwon, M.C., Proost, N., Song, J.Y., de Vries, H., Badhai, J., Sutherland, K., et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO Mol. Med. 6 (2014), 212–225.
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 212-225
-
-
Huijbers, I.J.1
Bin Ali, R.2
Pritchard, C.3
Cozijnsen, M.4
Kwon, M.C.5
Proost, N.6
Song, J.Y.7
de Vries, H.8
Badhai, J.9
Sutherland, K.10
-
20
-
-
0035893252
-
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
-
Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., Tuveson, D.A., Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15 (2001), 3243–3248.
-
(2001)
Genes Dev.
, vol.15
, pp. 3243-3248
-
-
Jackson, E.L.1
Willis, N.2
Mercer, K.3
Bronson, R.T.4
Crowley, D.5
Montoya, R.6
Jacks, T.7
Tuveson, D.A.8
-
21
-
-
0023267965
-
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course
-
Johnson, B.E., Ihde, D.C., Makuch, R.W., Gazdar, A.F., Carney, D.N., Oie, H., Russell, E., Nau, M.M., Minna, J.D., myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J. Clin. Invest. 79 (1987), 1629–1634.
-
(1987)
J. Clin. Invest.
, vol.79
, pp. 1629-1634
-
-
Johnson, B.E.1
Ihde, D.C.2
Makuch, R.W.3
Gazdar, A.F.4
Carney, D.N.5
Oie, H.6
Russell, E.7
Nau, M.M.8
Minna, J.D.9
-
22
-
-
0026494173
-
myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer
-
Johnson, B.E., Brennan, J.F., Ihde, D.C., Gazdar, A.F., myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. J. Natl. Cancer Inst. Monogr. 13 (1992), 39–43.
-
(1992)
J. Natl. Cancer Inst. Monogr.
, vol.13
, pp. 39-43
-
-
Johnson, B.E.1
Brennan, J.F.2
Ihde, D.C.3
Gazdar, A.F.4
-
23
-
-
0029681702
-
MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer
-
Johnson, B.E., Russell, E., Simmons, A.M., Phelps, R., Steinberg, S.M., Ihde, D.C., Gazdar, A.F., MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer. J. Cell Biochem. Suppl. 24 (1996), 210–217.
-
(1996)
J. Cell Biochem. Suppl.
, vol.24
, pp. 210-217
-
-
Johnson, B.E.1
Russell, E.2
Simmons, A.M.3
Phelps, R.4
Steinberg, S.M.5
Ihde, D.C.6
Gazdar, A.F.7
-
24
-
-
84874589027
-
Small cell lung cancer
-
Kalemkerian, G.P., Akerley, W., Bogner, P., Borghaei, H., Chow, L.Q., Downey, R.J., Gandhi, L., Ganti, A.K., Govindan, R., Grecula, J.C., et al. Small cell lung cancer. J. Natl. Compr. Canc. Net. 11 (2013), 78–98.
-
(2013)
J. Natl. Compr. Canc. Net.
, vol.11
, pp. 78-98
-
-
Kalemkerian, G.P.1
Akerley, W.2
Bogner, P.3
Borghaei, H.4
Chow, L.Q.5
Downey, R.J.6
Gandhi, L.7
Ganti, A.K.8
Govindan, R.9
Grecula, J.C.10
-
25
-
-
84896333670
-
Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing
-
McFadden, D.G., Papagiannakopoulos, T., Taylor-Weiner, A., Stewart, C., Carter, S.L., Cibulskis, K., Bhutkar, A., McKenna, A., Dooley, A., Vernon, A., et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156 (2014), 1298–1311.
-
(2014)
Cell
, vol.156
, pp. 1298-1311
-
-
McFadden, D.G.1
Papagiannakopoulos, T.2
Taylor-Weiner, A.3
Stewart, C.4
Carter, S.L.5
Cibulskis, K.6
Bhutkar, A.7
McKenna, A.8
Dooley, A.9
Vernon, A.10
-
26
-
-
84933509937
-
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
-
Melichar, B., Adenis, A., Lockhart, A.C., Bennouna, J., Dees, E.C., Kayaleh, O., Obermannova, R., DeMichele, A., Zatloukal, P., Zhang, B., et al. Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. Lancet Oncol. 16 (2015), 395–405.
-
(2015)
Lancet Oncol.
, vol.16
, pp. 395-405
-
-
Melichar, B.1
Adenis, A.2
Lockhart, A.C.3
Bennouna, J.4
Dees, E.C.5
Kayaleh, O.6
Obermannova, R.7
DeMichele, A.8
Zatloukal, P.9
Zhang, B.10
-
27
-
-
0141523025
-
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
-
Meuwissen, R., Linn, S.C., Linnoila, R.I., Zevenhoven, J., Mooi, W.J., Berns, A., Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4 (2003), 181–189.
-
(2003)
Cancer Cell
, vol.4
, pp. 181-189
-
-
Meuwissen, R.1
Linn, S.C.2
Linnoila, R.I.3
Zevenhoven, J.4
Mooi, W.J.5
Berns, A.6
-
28
-
-
84904063352
-
Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer
-
Mukhopadhyay, A., Berrett, K.C., Kc, U., Clair, P.M., Pop, S.M., Carr, S.R., Witt, B.L., Oliver, T.G., Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer. Cell Rep. 8 (2014), 40–49.
-
(2014)
Cell Rep.
, vol.8
, pp. 40-49
-
-
Mukhopadhyay, A.1
Berrett, K.C.2
Kc, U.3
Clair, P.M.4
Pop, S.M.5
Carr, S.R.6
Witt, B.L.7
Oliver, T.G.8
-
29
-
-
77950923924
-
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
-
Oliver, T.G., Mercer, K.L., Sayles, L.C., Burke, J.R., Mendus, D., Lovejoy, K.S., Cheng, M.H., Subramanian, A., Mu, D., Powers, S., et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev. 24 (2010), 837–852.
-
(2010)
Genes Dev.
, vol.24
, pp. 837-852
-
-
Oliver, T.G.1
Mercer, K.L.2
Sayles, L.C.3
Burke, J.R.4
Mendus, D.5
Lovejoy, K.S.6
Cheng, M.H.7
Subramanian, A.8
Mu, D.9
Powers, S.10
-
30
-
-
84876205922
-
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM
-
Osborne, J.K., Larsen, J.E., Shields, M.D., Gonzales, J.X., Shames, D.S., Sato, M., Kulkarni, A., Wistuba, I.I., Girard, L., Minna, J.D., Cobb, M.H., NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. Proc. Natl. Acad. Sci. USA 110 (2013), 6524–6529.
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 6524-6529
-
-
Osborne, J.K.1
Larsen, J.E.2
Shields, M.D.3
Gonzales, J.X.4
Shames, D.S.5
Sato, M.6
Kulkarni, A.7
Wistuba, I.I.8
Girard, L.9
Minna, J.D.10
Cobb, M.H.11
-
31
-
-
57849107571
-
Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma
-
Otto, T., Horn, S., Brockmann, M., Eilers, U., Schuttrumpf, L., Popov, N., Kenney, A.M., Schulte, J.H., Beijersbergen, R., Christiansen, H., et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 15 (2009), 67–78.
-
(2009)
Cancer Cell
, vol.15
, pp. 67-78
-
-
Otto, T.1
Horn, S.2
Brockmann, M.3
Eilers, U.4
Schuttrumpf, L.5
Popov, N.6
Kenney, A.M.7
Schulte, J.H.8
Beijersbergen, R.9
Christiansen, H.10
-
32
-
-
84866851740
-
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
-
Peifer, M., Fernandez-Cuesta, L., Sos, M.L., George, J., Seidel, D., Kasper, L.H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44 (2012), 1104–1110.
-
(2012)
Nat. Genet.
, vol.44
, pp. 1104-1110
-
-
Peifer, M.1
Fernandez-Cuesta, L.2
Sos, M.L.3
George, J.4
Seidel, D.5
Kasper, L.H.6
Plenker, D.7
Leenders, F.8
Sun, R.9
Zander, T.10
-
33
-
-
84941986957
-
Small cell lung cancer: will recent progress lead to improved outcomes?
-
Pietanza, M.C., Byers, L.A., Minna, J.D., Rudin, C.M., Small cell lung cancer: will recent progress lead to improved outcomes?. Clin. Cancer Res. 21 (2015), 2244–2255.
-
(2015)
Clin. Cancer Res.
, vol.21
, pp. 2244-2255
-
-
Pietanza, M.C.1
Byers, L.A.2
Minna, J.D.3
Rudin, C.M.4
-
34
-
-
84880559818
-
Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer
-
Poirier, J.T., Dobromilskaya, I., Moriarty, W.F., Peacock, C.D., Hann, C.L., Rudin, C.M., Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer. J. Natl. Cancer Inst. 105 (2013), 1059–1065.
-
(2013)
J. Natl. Cancer Inst.
, vol.105
, pp. 1059-1065
-
-
Poirier, J.T.1
Dobromilskaya, I.2
Moriarty, W.F.3
Peacock, C.D.4
Hann, C.L.5
Rudin, C.M.6
-
35
-
-
84948570001
-
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
-
Poirier, J.T., Gardner, E.E., Connis, N., Moreira, A.L., de Stanchina, E., Hann, C.L., Rudin, C.M., DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. Oncogene 34 (2015), 5869–5878.
-
(2015)
Oncogene
, vol.34
, pp. 5869-5878
-
-
Poirier, J.T.1
Gardner, E.E.2
Connis, N.3
Moreira, A.L.4
de Stanchina, E.5
Hann, C.L.6
Rudin, C.M.7
-
36
-
-
84994238857
-
Small cell lung cancer screen of oncology drugs, investigational agents, and gene and microRNA expression
-
Polley, E., Kunkel, M., Evans, D., Silvers, T., Delosh, R., Laudeman, J., Ogle, C., Reinhart, R., Selby, M., Connelly, J., et al. Small cell lung cancer screen of oncology drugs, investigational agents, and gene and microRNA expression. J. Natl. Cancer Inst., 108, 2016, 10.1093/jnci/djw122.
-
(2016)
J. Natl. Cancer Inst.
, vol.108
-
-
Polley, E.1
Kunkel, M.2
Evans, D.3
Silvers, T.4
Delosh, R.5
Laudeman, J.6
Ogle, C.7
Reinhart, R.8
Selby, M.9
Connelly, J.10
-
37
-
-
78249262321
-
Neuroendocrine tumors of the lung: an update
-
Rekhtman, N., Neuroendocrine tumors of the lung: an update. Arch. Pathol. Lab. Med. 134 (2010), 1628–1638.
-
(2010)
Arch. Pathol. Lab. Med.
, vol.134
, pp. 1628-1638
-
-
Rekhtman, N.1
-
38
-
-
84866849548
-
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
-
Rudin, C.M., Durinck, S., Stawiski, E.W., Poirier, J.T., Modrusan, Z., Shames, D.S., Bergbower, E.A., Guan, Y., Shin, J., Guillory, J., et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44 (2012), 1111–1116.
-
(2012)
Nat. Genet.
, vol.44
, pp. 1111-1116
-
-
Rudin, C.M.1
Durinck, S.2
Stawiski, E.W.3
Poirier, J.T.4
Modrusan, Z.5
Shames, D.S.6
Bergbower, E.A.7
Guan, Y.8
Shin, J.9
Guillory, J.10
-
39
-
-
0038342441
-
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
-
Sage, J., Miller, A.L., Perez-Mancera, P.A., Wysocki, J.M., Jacks, T., Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003), 223–228.
-
(2003)
Nature
, vol.424
, pp. 223-228
-
-
Sage, J.1
Miller, A.L.2
Perez-Mancera, P.A.3
Wysocki, J.M.4
Jacks, T.5
-
40
-
-
84940403711
-
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
-
Saunders, L.R., Bankovich, A.J., Anderson, W.C., Aujay, M.A., Bheddah, S., Black, K., Desai, R., Escarpe, P.A., Hampl, J., Laysang, A., et al. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci. Transl. Med., 7, 2015, 302ra136.
-
(2015)
Sci. Transl. Med.
, vol.7
, pp. 302ra136
-
-
Saunders, L.R.1
Bankovich, A.J.2
Anderson, W.C.3
Aujay, M.A.4
Bheddah, S.5
Black, K.6
Desai, R.7
Escarpe, P.A.8
Hampl, J.9
Laysang, A.10
-
41
-
-
77952794331
-
Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma
-
Schaffer, B.E., Park, K.S., Yiu, G., Conklin, J.F., Lin, C., Burkhart, D.L., Karnezis, A.N., Sweet-Cordero, E.A., Sage, J., Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 70 (2010), 3877–3883.
-
(2010)
Cancer Res.
, vol.70
, pp. 3877-3883
-
-
Schaffer, B.E.1
Park, K.S.2
Yiu, G.3
Conklin, J.F.4
Lin, C.5
Burkhart, D.L.6
Karnezis, A.N.7
Sweet-Cordero, E.A.8
Sage, J.9
-
42
-
-
84939603153
-
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
-
Schoffski, P., Besse, B., Gauler, T., de Jonge, M.J., Scambia, G., Santoro, A., Davite, C., Jannuzzo, M.G., Petroccione, A., Delord, J.P., Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study. Ann. Oncol. 26 (2015), 598–607.
-
(2015)
Ann. Oncol.
, vol.26
, pp. 598-607
-
-
Schoffski, P.1
Besse, B.2
Gauler, T.3
de Jonge, M.J.4
Scambia, G.5
Santoro, A.6
Davite, C.7
Jannuzzo, M.G.8
Petroccione, A.9
Delord, J.P.10
-
43
-
-
84938097346
-
Origins, genetic landscape, and emerging therapies of small cell lung cancer
-
Semenova, E.A., Nagel, R., Berns, A., Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29 (2015), 1447–1462.
-
(2015)
Genes Dev.
, vol.29
, pp. 1447-1462
-
-
Semenova, E.A.1
Nagel, R.2
Berns, A.3
-
44
-
-
84978388629
-
Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients
-
Semenova, E.A., Kwon, M.C., Monkhorst, K., Song, J.Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W.A., Smit, E.F., et al. Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients. Cell Rep. 16 (2016), 631–643.
-
(2016)
Cell Rep.
, vol.16
, pp. 631-643
-
-
Semenova, E.A.1
Kwon, M.C.2
Monkhorst, K.3
Song, J.Y.4
Bhaskaran, R.5
Krijgsman, O.6
Kuilman, T.7
Peters, D.8
Buikhuisen, W.A.9
Smit, E.F.10
-
45
-
-
84867627577
-
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
-
Sos, M.L., Dietlein, F., Peifer, M., Schottle, J., Balke-Want, H., Muller, C., Koker, M., Richters, A., Heynck, S., Malchers, F., et al. A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc. Natl. Acad. Sci. USA 109 (2012), 17034–17039.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 17034-17039
-
-
Sos, M.L.1
Dietlein, F.2
Peifer, M.3
Schottle, J.4
Balke-Want, H.5
Muller, C.6
Koker, M.7
Richters, A.8
Heynck, S.9
Malchers, F.10
-
46
-
-
79958761641
-
Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung
-
Sutherland, K.D., Proost, N., Brouns, I., Adriaensen, D., Song, J.Y., Berns, A., Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell 19 (2011), 754–764.
-
(2011)
Cancer Cell
, vol.19
, pp. 754-764
-
-
Sutherland, K.D.1
Proost, N.2
Brouns, I.3
Adriaensen, D.4
Song, J.Y.5
Berns, A.6
-
47
-
-
84862183087
-
Functional genomics identifies therapeutic targets for MYC-driven cancer
-
Toyoshima, M., Howie, H.L., Imakura, M., Walsh, R.M., Annis, J.E., Chang, A.N., Frazier, J., Chau, B.N., Loboda, A., Linsley, P.S., et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc. Natl. Acad. Sci. USA 109 (2012), 9545–9550.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 9545-9550
-
-
Toyoshima, M.1
Howie, H.L.2
Imakura, M.3
Walsh, R.M.4
Annis, J.E.5
Chang, A.N.6
Frazier, J.7
Chau, B.N.8
Loboda, A.9
Linsley, P.S.10
-
48
-
-
70349300528
-
Lung tumours with neuroendocrine differentiation
-
Travis, W.D., Lung tumours with neuroendocrine differentiation. Eur. J. Cancer 45:Suppl 1 (2009), 251–266.
-
(2009)
Eur. J. Cancer
, vol.45
, pp. 251-266
-
-
Travis, W.D.1
-
49
-
-
84860589522
-
Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
-
Travis, W.D., Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod. Pathol. 25:Suppl 1 (2012), S18–S30.
-
(2012)
Mod. Pathol.
, vol.25
, pp. S18-S30
-
-
Travis, W.D.1
-
50
-
-
84940100919
-
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
-
Travis, W.D., Brambilla, E., Nicholson, A.G., Yatabe, Y., Austin, J.H., Beasley, M.B., Chirieac, L.R., Dacic, S., Duhig, E., Flieder, D.B., et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10 (2015), 1243–1260.
-
(2015)
J. Thorac. Oncol.
, vol.10
, pp. 1243-1260
-
-
Travis, W.D.1
Brambilla, E.2
Nicholson, A.G.3
Yatabe, Y.4
Austin, J.H.5
Beasley, M.B.6
Chirieac, L.R.7
Dacic, S.8
Duhig, E.9
Flieder, D.B.10
-
51
-
-
34250739960
-
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
-
Wilkinson, R.W., Odedra, R., Heaton, S.P., Wedge, S.R., Keen, N.J., Crafter, C., Foster, J.R., Brady, M.C., Bigley, A., Brown, E., et al. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin. Cancer Res. 13 (2007), 3682–3688.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 3682-3688
-
-
Wilkinson, R.W.1
Odedra, R.2
Heaton, S.P.3
Wedge, S.R.4
Keen, N.J.5
Crafter, C.6
Foster, J.R.7
Brady, M.C.8
Bigley, A.9
Brown, E.10
-
52
-
-
77956369534
-
Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
-
Yang, D., Liu, H., Goga, A., Kim, S., Yuneva, M., Bishop, J.M., Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proc. Natl. Acad. Sci. USA 107 (2010), 13836–13841.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 13836-13841
-
-
Yang, D.1
Liu, H.2
Goga, A.3
Kim, S.4
Yuneva, M.5
Bishop, J.M.6
|